Botox Eases Migraines and Bruxism: New Real-World Insights

MigraineMind
Nov 27, 2025
1 min read

Research Summary

A fascinating study published in Toxins (Basel) reveals that OnabotulinumtoxinA (BoNTA) may offer dual benefits for individuals suffering from chronic migraine (CM) and bruxism. Conducted by the Greek Research Alliance for the Study of Headache and Pain, this research involved 58 patients undergoing two cycles of BoNTA treatment. Results showed a significant reduction in bruxism-related pain, with median scores dropping from 7 to 3 on a 0-10 scale. Additionally, 71% of patients reported improvements in migraine frequency, closely linked to reduced bruxism pain. This suggests BoNTA could effectively address both conditions, enhancing overall patient outcomes.

Study Details

📄 Title: OnabotulinumtoxinA to Prevent Chronic Migraine with Comorbid Bruxism: Real-World Data from the GRASP Study Group.

👥 Research Team: Argyriou AA et al.

📚 Published In: Toxins (Basel)

📅 Publication Date: 2025 Nov 3

⚕️ Medical Disclaimer: This summary is generated automatically from recent migraine research. Always consult with healthcare professionals for medical advice.